Liver Diseases  >>  AiTan (rivoceranib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AiTan (rivoceranib) / HLB Bio Group
NCT01192971: A Study of Apatinib in Patients With Advanced Hepatocellular Carcinoma

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Completed
2
121
RoW
Apatinib
Jiangsu HengRui Medicine Co., Ltd., Eighty-One Hospital of People's Liberation Army
Advanced Hepatocellular Carcinoma
07/13
07/13

Download Options